Pfizer/BioNTech SARS-CoV-2 vaccine as a potential trigger for the development of narcolepsy: a case report

Ala Mahamid 1, Robyn Jacob Bornstein 2, Hagay Amir 3 PMID: 35733336 PMCID: PMC9516586 DOI: 10.5664/jcsm.10134 J Clin Sleep Med. 2022 Oct 1;18(10):2503-2506. doi: 10.5664/jcsm.10134. Abstract Narcolepsy is a rare condition in Israel. Currently, the incidence of narcolepsy following SARS-CoV-2…[...]

Read More

Mesenteric thrombosis in patients with coronavirus disease: comprehensive assessment and treatment

Authors: A.R. Stasyshyn , .S. Stadnyk, A.I. Doroshak,I et. al., (Medical perspectives) 27(1):86-91 DOI:10.26641/2307-0404.2022.1.254332 Abstract Acute mesenteric circulatory disorder belongs to the most serious diseases of the abdominal cavity. Being an…[...]

Read More

Hematological Markers as Predictors of ICU Admission in COVID-19 Patients: A Case-Control Study From a Tertiary Hospital

Nor Hayati Ismail • Alaa Siddig • Muhammad ‘Akif, et. al. Published: July 10, 2024, DOI: 10.7759/cureus.64213  Abstract Background: COVID-19 illness severity ranges from mild- to life-threatening cases necessitating critical care. Rapid prediction of disease severity…[...]

Read More

Endothelial cell damage is the central part of COVID-19 and a mouse model
induced by injection of the S1 subunit of the spike protein

Authors: Gerard J. NuovoCynthia MagroToni ShafferHamdy AwadDavid SusterSheridan MikhailBing HeJean-Jacques MichailleBenjamin LiechtyEsmerina Tili Annals of Diagnostic Pathology ABS T R A C TNeurologic complications of symptomatic COVID-19 are common. Brain…[...]

Read More